SITE SEARCH | NEWS | EARNINGS | CALENDARS | MUTUAL FUNDS
Sector Tables: Energy - Retail - Utilities - REIT - Banks - Brokerage - ETFs | Oil Data
Login | Subscribe to Ticker
Market Update Analysis: 
Indian Stocks Defy Terror
Author: Elena Todorova
123jump.com
Last Update: 1:33 PM EDT July 12 2006


Although a series of blasts shook Mumbai on Tuesday evening, Indian stock market opened strong on Wednesday, undeterred by the terror attacks, and surged 3% supported by strong Q1 results from the IT sector. Infosys rose 8% and guided upward fiscal year 2007 earnings and revenue.

 
10:30AM Infosys Technologies boosts the benchmark Sensex.
The Sensex in India soared 315.74 points, or 2.9%, to 10,930.09, its highest closing level in nearly two months since 19 May 2006. The turnover on BSE was $600 million (Rs 3,120 crore), higher than Tuesday’s $500 million (Rs 2,414 crore). The market breadth moved towards positive during the close, with winners outnumbering losers by 9:1 on the Mumbai Stock Exchange. Overall 1,257 shares rose on BSE, 1,093 declined and 80 shares were unchanged.

Infosys surged and its results as well as forecasts helped boost a host of other IT stocks. The company advanced 7.8%, to Rs 3,397 on a huge volume of 1.31 million shares. Infosys turns ex-bonus (1:1 bonus) on the bourses tomorrow. Infosys reported a 50.3% growth in consolidated Q1 June 2006 net profit to Rs 800 crore from Rs 532 crore in Q1 June 2005. Sales rose 45.5% to Rs 3,015 crore from Rs 2,071 crore.

Many other IT stocks ended up, following Infosys performance. TCS climbed 7.4% to Rs 1,900, HCL Tech rose 8.9% to Rs 554.50, Wipro gained 3.9% to Rs 515, I-flex advanced 4% to Rs 1,285 and Satyam Computer added 4.4% to Rs 751.

Index large-cap Reliance Industries, having a huge 11.9% weightage in the Sensex, gained nearly 5%, to Rs 1,098.80 on 3.3 million shares. Engineering & construction company L&T gained 3.7% to Rs 2,250 on hopes of strong Q1 June 2006 results. The company has a strong order-book of $6 billion or Rs 24,000 crore.

Metal shares gained supported by firm metal prices on the London Metal Exchange. Hindalco advanced 7% to Rs 179.80, Sterlite Industries rose 4% to Rs 439 and Hindustan Zinc gained 2.7% to Rs 608.90. Cement stocks also recovered from their lower level on hopes of strong Q1 numbers. Gujarat Ambuja Cements gained 3.3%, to Rs 109.25, ACC advanced 2% to Rs 836, Grasim gained 2% to Rs 1,995 and UltraTech Cement climbed 1.8% to Rs 747.

Reliance Communications surged nearly 8%, to Rs 271.85 on 2.8 million shares. Power equipment company, BHEL, gained 2.2% to Rs 1,980. Car major Maruti Udyog jumped nearly 4% to Rs 818 on three times more than normal volume.


9:45AM Stocks opened near the flat line on economic report and Microsoft.
Stocks opened near the flat line Wednesday, reflecting a government report on trade deficit and a decline for Microsoft Corp. following an unfavorable EU antitrust ruling. The Commerce Department reported the trade imbalance rose by 0.8% in May to $63.8 billion, mainly due to higher oil prices. The increase was smaller than the 2.5% increase that economists expected but still represented the sixth largest deficit in history. Microsoft Corp. (MSFT: chart) fell about 1.5% after the EU fined the software company $357 million for failing to obey its 2004 antitrust order to share program code with rivals. Semiconductor stocks also moved to the downside, dragged by notable losses for STMicroelectronics (STM: chart), Infineon (IFX: chart), and Broadcom (BRCM: chart).

The gold sector showed continued strength as the price of the precious metal moved further upside after showing a strong upward move in the previous session. Some biotechnology stocks also posted strong gains, with Genzyme (GENZ: chart) up 4%, helping to lead the sector higher after reporting better-than-expected Q2 earnings and revenues. However, shares of Genentech (DNA: chart) dropped 3.4% after the company reported strong Q2 earnings but disappointing sales of its colon cancer drug Avastin. In the first hour of trading, the Dow Jones industrial average rose 9.85, or 0.09%.The Standard & Poor''s 500 index rose 0.13, or 0.01%, and the Nasdaq composite index fell 6.12, or 0.29%.


The U.S. trade deficit widened less than economists had expected.
Wednesday morning, the Department of Commerce released its report on U.S. international trade in goods and services in the month of May, showing that the U.S. trade deficit widened less than economists had expected. The Commerce Department said that the trade deficit widened to $63.8 billion from a revised $63.3 billion in April. Economists had expected the deficit to widen to $64.6 billion from the $63.4 billion originally reported for the previous month. The wider trade deficit came as an increase in imports outpaced an increase in exports, with imports rising to $182.5 billion in May from $179.3 billion in April while exports increased to $118.7 billion from $115.9 billion. The report also showed that the goods deficit widened to $70.1 billion in May from $69.6 billion in April while the services surplus was virtually unchanged at $6.2 billion. Imports of goods increased to $154.3 billion in May from $151.4 billion in April while exports of goods rose to $84.2 billion from $81.8 billion. At the same time, imports of services rose to $28.2 billion in May from $27.9 billion in April while exports of services rose to $34.4 billion from $34.1 billion. The Commerce Department also said that the politically sensitive trade deficit with China widened to $17.7 billion in May from $17.0 billion in April.


9:00AM Stock futures pointed to a flat opening.
U.S. stock futures showed slight weakness, indicating a flat market opening Wednesday. Tech stocks are expected to be under pressure after European antitrust regulators fined Microsoft Corp. The EU fined the world''s largest software maker about $357 million for not complying with a 2004 antitrust ruling.

In earnings news, shares of Genentech Inc. (DNA: chart) dropped more than 2% after the close on Tuesday. The biotechnology company reported Q2 earnings that increased from last year and beat analysts'' estimate on higher revenues, boosted by strong sales of its cancer drugs, including colon cancer drug Avastin. The company also raised its outlook for non-GAAP earnings per share growth for the full year 2006 to about 55% to 60% from its prior outlook of a 45% to 55% growth. Media company Gannett (GCI: chart) drug maker Genzyme Corp. (GENZ: chart) and M&T Bank Corp. (MTB: chart) are scheduled to report quarterly results on Wednesday.

In merger news, Premier Foods agreed to buy the UK and Irish businesses of Campbell Soup Co. (CPB: chart) for $846 million. Trading may also be impacted by traders'' reaction to the release of the Commerce Department''s report on U.S. international trade in goods and services. The trade deficit widened to $63.8 billion from a revised $63.3 billion in April. Economists had expected the deficit to widen to $64.6 billion from the $63.4 billion originally reported for the previous month. Standard & Poor''s 500 futures were down 0.90 point, but slightly above fair value. Dow Jones industrial average futures were down 4 points, and Nasdaq 100 futures were down 2 points.

Infosys Technologies,(INFY: chart), IT company, reported a Q1 profit of 62 cents a share, up from a profit of 43 cents a share a year-ago, beating analyst estimate for earnings of 55 cents a share on 38.7% revenue growth. Infosys expects earnings of 64 to 65 cents a share for Q2 and $2.70 to $2.73 a share for the year.

Wolverine World Wide Inc., (WWW: chart), sneaker maker, reported Q2 profit grew 7.4% to 25 cents a share, with revenue up 10.5%, led by the performance of its Merrell brand. Q2 included 3 cents a share expenses from stock incentives and investment spending. The company lifted 2006 earnings and revenue guidance. It now expects 2006 earnings between $1.38 and $1.42 a share, up from $1.34 to $1.40. The company beat analyst expectations for earnings of 23 cents a share.

Ruby Tuesday (RI: chart), dining restaurants operator, reported Q4 net income of 53 cents a share, up 22% from the 40 cents of a year ago on 23% revenue growth while same-store sales at company-owned restaurants rose 2.9%. The company beat analysts’ estimate for earnings of 51 cents a share.

Genentech Inc, (DNA: chart), biotechnology company, reported Q2 net earnings of 49 cents a share, up from 27 cents a share in the year-ago period. Operating revenue advanced to $2.2 billion from $1.53 billion. If not for one-time items, Genentech per-share profit amounted to 56 cents vs. 30 cents in Q2 of 2005. The company topped analysts views for earnings of 47 cents a share.

Gannett Inc,(GCI: chart), newspaper publisher, reported a Q2 net income of $1.31 a share, down from $1.37 a share despite revenue growth to $2.03 billion from $1.91 billion, matching analysts expectations earnings of $1.31 a share on revenue of $2.02 billion.
  1  2

 

 
About Us | Contact Us | Privacy Policy | Disclaimer

©1999-2009 123jump.com. All rights reserved